相关实验视频

Updated: Jun 14, 2025

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

原始艾滋病毒患者的功能储备

Carlos G Musso¹, Rossina Juarez², W Belloso³

¹Research Department, Hospital Italiano de Buenos Aires. Buenos Aires, Argentina.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

|September 7, 2024

概括

在尚未接受治疗的HIV患者中,功能储备 (RFR) 保持不变,但明显低于健康人群. 这一发现突显了早期艾滋病毒感染中功能变化的潜力.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
传染性疾病传染性疾病
免疫学免疫学免疫学

背景情况:

功能储备 (RFR) 是脏在刺激后至少增加20%的膜过率 (GFR) 的能力.
与艾滋病毒相关的病症可以表现为GFR降低,瘤综合征和管管功能障碍.
早期发现艾滋病毒患者的脏变化至关重要,特别是那些未接受过治疗的人.

研究的目的:

预期评估尚未开始抗逆转录病毒治疗的HIV阳性患者的功能储备 (RFR).

主要方法:

用cimetidine辅助肌素清除率 (CACC) 测量了淋巴膜过率 (GFR).
用Hellerstein等人描述的方法评估了功能储备 (RFR).
该研究包括12名未接受治疗的艾滋病毒患者和9名健康志愿者.

主要成果:

所有12名未接受治疗的艾滋病毒患者都显示出阳性RFR (24.8±2%).
这一RFR明显低于在9名健康对照人群中观察到的RFR (90.3±5%).

结论:

在未接受治疗的艾滋病毒患者中存在功能储备.
然而,与血清阴性健康个体相比,该队列中的RFR显著下降,这表明早期功能受损.

关键词:

艾滋病病毒艾滋病病毒艾滋病病毒脏生理学的脏生理学脏储备:脏储备是指脏的储备.

更多相关视频

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Humanized NOD/SCID/IL2rγ^null (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

相关概念视频

Factors Affecting Renal Clearance: Renal Impairment

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

Renal Failure: Dose Adjustments

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...